SecBot SecBot
25-NSE ·Filed Jul 15, 2026

CPRX

CATALYST PHARMACEUTICALS, INC.
BEARISH
Impact 9/10
Horizonimmediate Processed4mo ago SEC0001354457-26-000694
Actionable Insight ▼ Bearish

Traders should expect a sharp decline in CPRX shares upon delisting. The stock will likely move to the OTC markets with significantly reduced liquidity. Any remaining positions should be evaluated for exit before the delisting takes full effect. Monitor for any subsequent going-private transaction or bankruptcy filing.

DirectionBearish
Confidencehigh
Horizonimmediate

How the stock moved after the report

BEARISH VIEWSTOCK AT ENTRY AT T+5
Entry
$31.49
T+0 close · Jul 15, 2026 · via day close
Latest settled
0.00%
T+5 · $31.49
Vs SPY
+0.98%
α at T+5
Next horizon
T+20
due 3mo ago
  1. T+0 · Jul 15 $31.49entry
  2. T+1 · 4mo ago 0.00%α +0.54% · $31.49
  3. T+5 · 4mo ago 0.00%α +0.98% · $31.49
  4. T+20 · due 3mo ago Pending
  5. T+60 · due 6w ago Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Nasdaq filed a Form 25-NSE to delist Catalyst Pharmaceuticals' common stock under Rule 12d2-2(a)(3), effective immediately on July 15, 2026. This is a mandatory removal initiated by the exchange, not a voluntary delisting, and represents a severe negative event for a $3.9B market-cap company.

Key Facts

  • Nasdaq Stock Market LLC filed Form 25-NSE to remove Catalyst Pharmaceuticals' common stock from listing and registration.
  • The delisting is under 17 CFR 240.12d2-2(a)(3), which covers securities that have been redeemed, retired, or matured, but here it is an exchange-initiated removal.
  • The filing was made effective on July 15, 2026.
  • Catalyst Pharmaceuticals has a market cap of approximately $3.9B, making this a significant event.

Financial Impact

Delisting from Nasdaq, loss of exchange listing, likely severe price decline, reduced liquidity, and potential forced selling by institutional holders.

liquiditymarket capitalizationstock price

Risk Factors

  • Complete loss of exchange listing and trading halts.
  • Forced selling by institutional investors who cannot hold OTC stocks.
  • Potential default on debt covenants tied to exchange listing.
  • Risk of further regulatory or legal actions.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
0% bullish (9 analysts)

Investment Themes

Documents Analyzed

This report is based on 8 SEC documents filed with EDGAR.

DocumentAccession Number
25-NSE Filing (CPRX), Batch item 10001354457-26-000694
Document: 0001354457-26-000694-index-headers.html0001354457-26-000694
Document: 0001354457-26-000694-index.html0001354457-26-000694
Document: 0001354457-26-000694.txt0001354457-26-000694
25-NSE Filing (CPRX), Batch item 50001354457-26-000694
Document: 0001354457-26-000694-index-headers.html0001354457-26-000694
Document: 0001354457-26-000694-index.html0001354457-26-000694
Document: 0001354457-26-000694.txt0001354457-26-000694

Track record

16 reports on CPRX

Performance horizon

4 of 6 bullish or bearish reports moved the stock their way by T+20. Best: +25.72% at T+60 after the Feb 25, 2026 report. 6 of 8 went positive at some point.

Filters
  1. Nov 4, 202612d ago Institutional Cluster Bearish 4/10 No price data
  2. Aug 22, 202612w ago Institutional Cluster Mixed 5/10 No price data
  3. Jul 24, 202616w ago 15-12G Bearish 9/10 Entry $31.49 No price data
  4. Jul 17, 202617w ago EFFECT Bearish 5/10 Entry $31.49 No price data
  5. Jul 15, 202617w ago 25-NSE Bearish 9/10 Viewing Entry $31.49 No price data
  6. Jul 8, 202618w ago 8-K Bullish 6/10 Entry $31.47 No price data
  7. Jun 30, 202619w ago DEFA14A Neutral 3/10 Entry $31.44 No price data
  8. Jun 30, 202619w ago 8-K Neutral 4/10 Entry $31.44 No price data
  9. May 28, 202624w ago PREM14A Bullish 8/10 Entry $31.23 to $31.46 ▲ +0.74% +2.53% vs SPY
  10. May 12, 202626w ago DEFA14A Neutral 3/10 Entry $31.14 to $31.34 ▲ +0.64% +2.37% vs SPY
Showing 10 of 16

US Market Status

Market Closed · Opens in 6h 35m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 15, 2026